Monograph

B02AA02 - Tranexamic Acid

Not porphyrinogenic

Rationale

Aminoacid. No CYP-interactions.

Chemical description

Amino acid plasmin inhibitor administered as tablets or infusion in situations with fibrinolysis or risk for fibrinolytic bleeding. Metabolized by acetylation and deamination

IPNet drug reports

Uneventful use reported in 4 patients with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes B02A / B02AA or go back.

Tradenames

This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Show more details and information about the listed tradenames